Atinum Investment overview
Atinum Investment contact information
Offices
9, Teheran-ro 103-gil, Gangnam-gu (2nd and 3rd floors, Jeil Building, Samseong-dong), , Seoul, , South KoreaContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Sangmin (David) Lim | Job titleInvestment Director | LocationSeoul, South Korea | Email  ----------- |
| Key ContactMr. Heejae Jung | Job titleDirector, Investments | LocationSeoul, South Korea | Email ---------- |
| Mr. Ki Chun Shin | Job titleChief Executive Officer, Vice Chairman | LocationSeoul, South Korea | Email ------ |
| Mr. Sang Hoon Kwak | Job titleChief Managing Director | LocationSeoul, South Korea | Email ---------- |
Atinum Investment fund commitments
Known fund commitments: 13
| Fund | Manager | Commitment date | Commitment size |
|---|---|---|---|
Manager ----------- | Commitment dateSep 2022 | Commitment size$479.385k | |
Manager ------- | Commitment dateJun 2023 | Commitment size --------- | |
Manager --------- | Commitment dateSep 2023 | Commitment size ----- | |
Atinum Investment funds managed
Funds in market: 1
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size --------- | Open date- | Strategy ----------- | |
Closed funds: 5
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ------ | Close dateDec 2020 | Strategy --------- | |
Fund size --------- | Close dateDec 2017 | Strategy ----------- | |
Fund size ---------- | Close dateMay 2016 | Strategy ----------- | |
Stories that mention Atinum Investment
Chequer takes in $17.75m
Chequer, a San Jose, California-based provider of the QueryPie modern data governance platform, has secured $17.75 million in funding.
Valo Health closes $190m Series B led by PSP Investments
Boston-based Valo Health, a technology company that uses human-centric data and machine learning for drug discovery and development, has closed a $190 million Series B financing.
Berkeley Lights snags $95 mln
Berkeley Lights Inc, a digital cell biology company, has closed $95 million in funding. Nikon led the round with participation from Sequoia Capital, Walden-Riverwood Ventures, Black Diamond Ventures, Paxion Capital, Cota Capital, KTB Network, Atinum Investment, Shangbay Capital, AJS BioTree Healthcare Fund and Varian.
ExoCoBio takes in $27 mln Series B
South Korea-based ExoCoBio Inc, an exosome startup, has raised about $27 million in Series B funding. The investors included Seven Tree Equity Partners, Csquared Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital, Atinum Investment, GU Equity Partners and Quantum Ventures Korea.
Profusa garners over $45 mln Series C
South San Francisco-based Profusa, a developer of tissue-integrating biosensors for continuous monitoring of body chemistries, has raised more than $45 million in Series C financing. The backers were VMS Investment Group, Tasly Pharmaceutical Group, Maxim Integrated Ventures, 3E Bioventures Capital and Atinum Investment.
ExoCoBio lands $11 mln Series A
South Korea-based ExoCoBio Inc, a developer of exosome-based cosmeceuticals and biopharmaceuticals for skin and tissue regeneration, has secured $11 million in its Series A funding. The investors included SBI Investment, Atinum Investment, ID Ventures and Dt&Investment.